Generic drug
Milnacipran price, strengths & recalls
Generic of Savella
Pharmacies pay $81.81 for 30 tablets of Milnacipran 100 mg tablet this week, and from $36.45 to $84.90 across its 4 priced strengths and forms. 4 manufacturers make it. Its official label last changed on September 16, 2026.
Generic- Fair cash price
- $104.58
- Strengths
- 4
- Makers
- 4
- Updated
- Nov 11
Milnacipran price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 12.5 mg tablet | $1.22 | $36.45 / 30 tablets |
| 25 mg tablet | $2.38 | $71.52 / 30 tablets |
| 50 mg tablet | $2.83 | $84.90 / 30 tablets |
| 100 mg tablet | $2.73 | $81.81 / 30 tablets |
The lowest cost per tablet is 12.5 mg tablet at $1.22. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Brand names of milnacipran
A brand and its generic share the active ingredient; the generic is almost always far cheaper.
Supply status: shortages & recalls
What people paid for Milnacipran
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use MILNACIPRAN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for MILNACIPRAN HYDROCHLORIDE TABLETS. MILNACIPRAN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 2009
BOXED WARNING
WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS
Milnacipran hydrochloride tablets are selective serotonin and norepinephrine reuptake inhibitor (SNRI), similar to some drugs used for the treatment of depression and other psychiatric disorders. Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of such drugs in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on milnacipran hydrochloride tablets should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Milnacipran hydrochloride tablets are not approved for use in the treatment of major depressive disorder. Milnacipran hydrochloride tablets are not approved for use in pediatric patients [see Indications and Usage (1), Warnings and Precautions (5.1), Use in Specific Populations (8.4)].
WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS
See full prescribing information for complete boxed warning.• Increased risk of suicidal ideation, thinking, and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder (MDD) and other psychiatric disorders (5.1).
• Milnacipran hydrochloride tablets are not approved for use in pediatric patients (1, 8.4).
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA022256 · Abbvie
- First approved
- January 14, 2009 (17 years ago)
- Latest approved change
- September 10, 2025
- Approved label
- PDF, Sep 11, 2025
- Generic makers
- 3 approved generic applications on the market
- Last patent listed
- September 19, 2029
Milnacipran questions
How much does milnacipran cost without insurance?
Pharmacies pay about $81.81 for 30 tablets of milnacipran 100 mg tablet ($2.73 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $104.58. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
What is the brand name of milnacipran?
Milnacipran is sold as Savella. The generic has the same active ingredient and usually costs far less.
Is milnacipran in shortage?
No shortage is reported for milnacipran right now. We check the national shortage list every day.
Has milnacipran been recalled?
No recalls are on record for milnacipran.
When did the milnacipran label last change?
The official label was last updated on September 16, 2026 (version 1). See what changed.
Talk about milnacipran
No comments yet. Questions, tips, what worked for you - start the conversation.